225 related articles for article (PubMed ID: 33446797)
1. S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell-cell interactions with adjacent breast cancer cells.
Jo SH; Heo WH; Son HY; Quan M; Hong BS; Kim JH; Lee HB; Han W; Park Y; Lee DS; Kwon NH; Park MC; Chae J; Kim JI; Noh DY; Moon HG
Sci Rep; 2021 Jan; 11(1):1337. PubMed ID: 33446797
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts induce an aggressive phenotypic shift in non-malignant breast epithelial cells via interleukin-8 and S100A8.
Lim H; Koh M; Jin H; Bae M; Lee SY; Kim KM; Jung J; Kim HJ; Park SY; Kim HS; Moon WK; Hwang S; Cho NH; Moon A
J Cell Physiol; 2021 Oct; 236(10):7014-7032. PubMed ID: 33748944
[TBL] [Abstract][Full Text] [Related]
3. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
[TBL] [Abstract][Full Text] [Related]
4. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Cormier K; Harquail J; Ouellette RJ; Tessier PA; Guerrette R; Robichaud GA
Anticancer Agents Med Chem; 2014 Jan; 14(1):35-45. PubMed ID: 24041228
[TBL] [Abstract][Full Text] [Related]
5. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition.
Yin C; Li H; Zhang B; Liu Y; Lu G; Lu S; Sun L; Qi Y; Li X; Chen W
Breast Cancer Res Treat; 2013 Nov; 142(2):297-309. PubMed ID: 24177755
[TBL] [Abstract][Full Text] [Related]
6. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin Induces an Epithelial to Mesenchymal Transition-Like Process in Mammary Epithelial Cells MCF10A.
Ordoñez-Moreno A; Rodriguez-Monterrosas C; Cortes-Reynosa P; Perez-Carreon JI; Perez Salazar E
J Cell Biochem; 2017 Sep; 118(9):2983-2992. PubMed ID: 28247960
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles from women with breast cancer promote an epithelial-mesenchymal transition-like process in mammary epithelial cells MCF10A.
Galindo-Hernandez O; Gonzales-Vazquez C; Cortes-Reynosa P; Reyes-Uribe E; Chavez-Ocaña S; Reyes-Hernandez O; Sierra-Martinez M; Salazar EP
Tumour Biol; 2015 Dec; 36(12):9649-59. PubMed ID: 26150337
[TBL] [Abstract][Full Text] [Related]
9. Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation.
Lee JH; Hallis SP; Kwak MK
Arch Pharm Res; 2024 May; 47(5):465-480. PubMed ID: 38734854
[TBL] [Abstract][Full Text] [Related]
10. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
11. S100A8 and S100A9, both transcriptionally regulated by PU.1, promote epithelial-mesenchymal transformation (EMT) and invasive growth of dermal keratinocytes during scar formation post burn.
Xu Z; Cheng C; Kong R; Liu Y; Wang S; Ma Y; Xing X
Aging (Albany NY); 2021 Jun; 13(11):15523-15537. PubMed ID: 34099591
[TBL] [Abstract][Full Text] [Related]
12. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.
Arai K; Takano S; Teratani T; Ito Y; Yamada T; Nozawa R
Curr Cancer Drug Targets; 2008 Jun; 8(4):243-52. PubMed ID: 18537548
[TBL] [Abstract][Full Text] [Related]
13. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
[TBL] [Abstract][Full Text] [Related]
14. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
15. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes.
Nedjadi T; Evans A; Sheikh A; Barerra L; Al-Ghamdi S; Oldfield L; Greenhalf W; Neoptolemos JP; Costello E
BMC Cancer; 2018 Dec; 18(1):1255. PubMed ID: 30558665
[TBL] [Abstract][Full Text] [Related]
16. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis.
Singh P; Ali SA; Kumar S; Mohanty AK
J Proteomics; 2023 Sep; 288():104981. PubMed ID: 37544501
[TBL] [Abstract][Full Text] [Related]
18. IL-1 receptor regulates S100A8/A9-dependent keratinocyte resistance to bacterial invasion.
Sorenson BS; Khammanivong A; Guenther BD; Ross KF; Herzberg MC
Mucosal Immunol; 2012 Jan; 5(1):66-75. PubMed ID: 22031183
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-α and MMP-9.
Lee S; Lee E; Ko E; Ham M; Lee HM; Kim ES; Koh M; Lim HK; Jung J; Park SY; Moon A
Cancer Lett; 2018 Nov; 437():25-34. PubMed ID: 30165193
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
Grebhardt S; Veltkamp C; Ströbel P; Mayer D
Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
